HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peng Xu Selected Research

O Antigens (O Antigen)

11/2021Scalable production and immunogenicity of a cholera conjugate vaccine.
7/2021Correction: Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.
1/2021Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine.
1/2021Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.
11/2020Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility.
11/2019Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba.
1/2019Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults.
1/2019Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.
1/2018Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.
1/2018Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peng Xu Research Topics

Disease

151Neoplasms (Cancer)
12/2022 - 12/2007
47Infections
06/2022 - 01/2005
37Inflammation (Inflammations)
06/2022 - 10/2005
30Breast Neoplasms (Breast Cancer)
08/2022 - 01/2012
23Cholera
11/2022 - 10/2011
21Neoplasm Metastasis (Metastasis)
08/2022 - 05/2011
19Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2013
18Carcinogenesis
08/2022 - 02/2010
16Hypoxia (Hypoxemia)
01/2022 - 01/2010
16Glioma (Gliomas)
06/2020 - 06/2008
14Rheumatoid Arthritis
07/2022 - 06/2011
13Wounds and Injuries (Trauma)
01/2022 - 05/2011
11Osteoarthritis
04/2022 - 06/2011
11Glioblastoma (Glioblastoma Multiforme)
01/2022 - 01/2010
10Pain (Aches)
12/2022 - 03/2005
9Pre-Eclampsia (Preeclampsia)
10/2022 - 01/2012
8Nasopharyngeal Carcinoma
12/2022 - 02/2010
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 02/2011
8Hypertension (High Blood Pressure)
04/2022 - 01/2017
8Kashin-Beck Disease
01/2022 - 04/2008
8Tuberculosis (Tuberculoses)
01/2022 - 01/2009
8Stroke (Strokes)
11/2021 - 01/2019
8Melanoma (Melanoma, Malignant)
01/2021 - 11/2017
8Thrombosis (Thrombus)
10/2020 - 06/2005
8Myocardial Infarction
04/2020 - 07/2006
7Fibrosis (Cirrhosis)
01/2022 - 01/2014
7Pancreatic Neoplasms (Pancreatic Cancer)
05/2021 - 12/2015
7Type 2 Diabetes Mellitus (MODY)
04/2021 - 07/2017
7Infarction (Infarctions)
01/2019 - 12/2012
6Necrosis
07/2022 - 07/2011
6Chronic Renal Insufficiency
06/2022 - 09/2015
6Body Weight (Weight, Body)
04/2022 - 12/2013
6COVID-19
02/2022 - 01/2020
6Triple Negative Breast Neoplasms
12/2021 - 01/2018
6Hepatocellular Carcinoma (Hepatoma)
06/2021 - 11/2005
6Sepsis (Septicemia)
01/2021 - 01/2007
6Hemorrhage
12/2020 - 07/2017
6Urinary Bladder Neoplasms (Bladder Cancer)
09/2020 - 01/2013
6Obesity
08/2020 - 04/2015
6Knee Osteoarthritis
06/2020 - 03/2005
6Reperfusion Injury
01/2020 - 05/2011
6Osteoporosis
07/2017 - 03/2005
5Disease Progression
07/2022 - 09/2016
5Osteosarcoma (Osteogenic Sarcoma)
06/2022 - 09/2014
5Psoriasis (Pustulosis Palmaris et Plantaris)
06/2022 - 05/2020
5Cardiovascular Diseases (Cardiovascular Disease)
04/2022 - 07/2015
5Acute Kidney Injury (Acute Renal Failure)
02/2022 - 03/2011
5Proteinuria
01/2022 - 07/2019
5Nausea
05/2021 - 08/2019

Drug/Important Bio-Agent (IBA)

77Proteins (Proteins, Gene)FDA Link
10/2022 - 01/2008
35Pharmaceutical PreparationsIBA
12/2022 - 03/2005
32Messenger RNA (mRNA)IBA
06/2022 - 02/2010
31Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2011
29MicroRNAs (MicroRNA)IBA
03/2022 - 10/2009
21Biological ProductsIBA
01/2022 - 04/2011
18AntigensIBA
10/2022 - 11/2005
17CytokinesIBA
07/2022 - 01/2015
16Therapeutic UsesIBA
01/2022 - 12/2006
16O Antigens (O Antigen)IBA
11/2021 - 11/2012
13Long Noncoding RNAIBA
05/2022 - 01/2018
12Small Interfering RNA (siRNA)IBA
08/2022 - 12/2009
11AntibodiesIBA
01/2021 - 10/2005
10Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2016
10DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2011
10Cholera VaccinesFDA Link
11/2021 - 06/2013
10RNA (Ribonucleic Acid)IBA
01/2021 - 01/2016
10Immunoglobulin M (IgM)IBA
01/2021 - 10/2011
10LipopolysaccharidesIBA
12/2020 - 11/2012
9VaccinesIBA
11/2022 - 10/2011
9EnzymesIBA
06/2022 - 10/2011
9Peptides (Polypeptides)IBA
01/2022 - 06/2008
8CollagenIBA
01/2021 - 04/2008
7Polysaccharides (Glycans)IBA
11/2022 - 06/2013
7Fatty Acids (Saturated Fatty Acids)IBA
04/2022 - 07/2017
7Hyaluronic Acid (Hyaluronan)IBA
02/2022 - 03/2005
7Immunoglobulin A (IgA)IBA
01/2021 - 05/2014
7Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2014
7Immunoglobulin G (IgG)IBA
01/2021 - 10/2011
6Matrix Metalloproteinases (MMPs)IBA
01/2022 - 06/2008
6Oxygen (Dioxygen)IBA
01/2022 - 09/2014
6Phosphotransferases (Kinase)IBA
01/2022 - 01/2013
6Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 05/2011
6Conjugate VaccinesIBA
11/2021 - 10/2011
6ErbB Receptors (EGF Receptor)IBA
09/2021 - 09/2010
6Viral DNAIBA
10/2020 - 01/2017
6Photosensitizing Agents (Photosensitizers)IBA
01/2020 - 01/2012
5SolutionsIBA
12/2022 - 07/2019
5ChemokinesIBA
06/2022 - 01/2007
5C-Reactive ProteinIBA
04/2022 - 07/2015
5LipidsIBA
01/2022 - 04/2019
5LigandsIBA
01/2022 - 12/2015
5Caspase 3 (Caspase-3)IBA
01/2022 - 10/2009
5Peptide Hydrolases (Proteases)FDA Link
01/2022 - 01/2017
5Antiviral Agents (Antivirals)IBA
01/2022 - 10/2020
5salicylhydroxamic acid (SHAM)IBA
11/2021 - 06/2005

Therapy/Procedure

58Therapeutics
10/2022 - 07/2005
13Radiotherapy
09/2021 - 02/2010
11Drug Therapy (Chemotherapy)
08/2022 - 01/2013
8Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2022 - 01/2014
6Intra-Articular Injections
02/2021 - 03/2005